Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Biocytogen and FineImmune Partner on Cell Therapies Targeting Intracellular Antigens

publication date: Sep 20, 2022

Beijing Biocytogen Pharma formed a strategic collaboration with Guangzhou FineImmune Biotech to co-develop cell-based therapeutic drugs targeting intracellular tumor-associated antigens. Initially, Biocytogen will use its proprietary TCR-mimic antibody platform to discover antibody sequences that will be further developed using FineImmune’s proprietary cell therapy platform. Because most tumor antigens are intracellular, Biocytogen has developed its TCR-mimic platform to discover antibodies to these targets, which can be developed into T cell engagers, bispecific/multispecific antibodies and CAR-T therapies. The FineImmune collaboration will apply Biocytogen-discovered antibodies in cell therapies. More details....

Stock Symbol: (HK: 02315)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here